Cyclooxygenase
Cyclooxygenase(环氧合酶)
Cyclooxygenase 相关产品(503)
- GC522069-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2 (potassium salt)CAS: 122576-55-0纯度: >98.00%
A potent PGE 2 analog
- GC522275-(3',4'-Dihydroxyphenyl)-γ-ValerolactoneCAS: 21618-92-8纯度: >95.00%
An active metabolite of various polyphenols
- GC52264Latanoprost tris(triethylsilyl) etherCAS: 477884-78-9纯度: >95.00%
A precursor in the synthesis of latanoprost
- GC524135-Aminosalicylic Acid-d7纯度: >99.00%
An internal standard for the quantification of 5-aminosalicylic acid
- GC5251115(S)-15-methyl Prostaglandin F2α ethyl amide纯度: >95.00%
Analog of 15(S)- 15- methyl PGF 2α methyl ester
- GC916804-Acetamido AntipyrineCAS: 83-15-8纯度: >95.00%
4-Acetamido antipyrine (4-AAAP) is an active metabolite of the non-opioid analgesic and antipyretic prodrug metamizole .
- GC91681Loxoprofen-SRSCAS: 83648-76-4纯度: >98.00%
Loxoprofen-SRS is a non-steroidal anti-inflammatory drug (NSAID) and COX inhibitor (IC50s = 0.5 and 0.39 for recombinant human COX-1 and COX-2, respectively) and an active metabolite of the prodrug loxoprofen .
- GC91909Fenoprofen-13C6 (sodium salt hydrate)CAS: 2687960-29-6纯度: >98.00%
Fenoprofen-13C6 (sodium salt hydrate)旨在用作通过GC或LC-MS定量非诺洛芬的内标。
- GC91921FenclofenacCAS: 34645-84-6纯度: >95.00%
Fenclofenac是一种非甾体抗炎药（NSAID）和COX抑制剂（COX-1和COX-2的IC50分别为7和4μM）。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC52203 | 16-phenyl tetranor Prostaglandin E1 | 52344-27-1 | >98.00% | |
A stable PGE 1 analog | ||||
| GC52204 | δ17-U-46619 | 946602-01-3 | >98.00% | |
A stable TXA 3 analog | ||||
| GC52205 | 8,11-Eicosadiynoic Acid | 82073-91-4 | >95.00% | |
An acetylenic fatty acid | ||||
| GC52206 | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2 (potassium salt) | 122576-55-0 | >98.00% | |
A potent PGE 2 analog | ||||
| GC52227 | 5-(3',4'-Dihydroxyphenyl)-γ-Valerolactone | 21618-92-8 | >95.00% | |
An active metabolite of various polyphenols | ||||
| GC52264 | Latanoprost tris(triethylsilyl) ether | 477884-78-9 | >95.00% | |
A precursor in the synthesis of latanoprost | ||||
| GC52270 | Pranoprofen-13C-d3 | - | >99.00% | |
An internal standard for the quantification of pranoprofen | ||||
| GC52377 | Prostaglandin A2 ethyl ester | - | >95.00% | |
An ester form of PGA 2 | ||||
| GC52413 | 5-Aminosalicylic Acid-d7 | - | >99.00% | |
An internal standard for the quantification of 5-aminosalicylic acid | ||||
| GC52511 | 15(S)-15-methyl Prostaglandin F2α ethyl amide | - | >95.00% | |
Analog of 15(S)- 15- methyl PGF 2α methyl ester | ||||
| GC52516 | Erbstatin | 100827-28-9 | >90.00% | |
A tyrosine kinase inhibitor | ||||
| GC60311 | PTUPB | 1287761-01-6 | >99.50% / >98.00% | |
PTUPB是一种新型的COX-2和sEH双抑制剂，IC 50 值分别为 1.26 nM 和 0.9μM。 | ||||
| GC61843 | Mofezolac | 78967-07-4 | >98.50% | |
A COX-1 inhibitor | ||||
| GC90701 | CAY10795 | 2241676-74-2 | >98.00% | |
一种15-PGDH抑制剂 | ||||
| GC90889 | 5-(3'-Hydroxyphenyl)-γ-Valerolactone | 21618-91-7 | >95.00% | |
多种多酚的代谢产物。 | ||||
| GC90930 | UT-11 | - | >98.00% | |
一种mPGES-1抑制剂 | ||||
| GC91088 | AMX12006 | 2639775-01-0 | >98.00% | |
一种EP4受体拮抗剂 | ||||
| GC91241 | 9-keto Tafluprost | 261179-75-3 | >95.00% | |
一种塔夫罗普斯特的衍生物。 | ||||
| GC91242 | 9-keto Latanoprost | 141074-06-8 | >98.00% | |
一种拉坦前列素的衍生物。 | ||||
| GC91680 | 4-Acetamido Antipyrine | 83-15-8 | >95.00% | |
4-Acetamido antipyrine (4-AAAP) is an active metabolite of the non-opioid analgesic and antipyretic prodrug metamizole . | ||||
| GC91681 | Loxoprofen-SRS | 83648-76-4 | >98.00% | |
Loxoprofen-SRS is a non-steroidal anti-inflammatory drug (NSAID) and COX inhibitor (IC50s = 0.5 and 0.39 for recombinant human COX-1 and COX-2, respectively) and an active metabolite of the prodrug loxoprofen . | ||||
| GC91909 | Fenoprofen-13C6 (sodium salt hydrate) | 2687960-29-6 | >98.00% | |
Fenoprofen-13C6 (sodium salt hydrate)旨在用作通过GC或LC-MS定量非诺洛芬的内标。 | ||||
| GC91921 | Fenclofenac | 34645-84-6 | >95.00% | |
Fenclofenac是一种非甾体抗炎药（NSAID）和COX抑制剂（COX-1和COX-2的IC50分别为7和4μM）。 | ||||